GlassScriptPhysician profile
John Keith Hayes
NPI 1275672933
$1,470.10
in general payments reported to CMS, 2019-2025
19 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2021: $230 · 2022: $121 · 2023: $489 · 2024: $144 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $302.09 | 2021-2025 | Spaceoar Vue System - 10ml |
| Reflexion Medical, INC. | $269.34 | 2023 | Reflexion Medical Radiotherapy System |
| Accuray Incorporated | $153.96 | 2019 | |
| Varian Medical Systems, INC. | $138.26 | 2019 | |
| Elekta, INC. | $133.55 | 2021 | |
| Abbvie INC. | $99.43 | 2019-2023 | |
| Siemens Medical Solutions USA, INC. | $59.54 | 2024 | Truebeam |
| Daiichi Sankyo INC. | $48.86 | 2024-2025 | Enhertu |
| Gt Medical Technologies, INC | $38.74 | 2025 | Gammatile |
| Pacira Pharmaceuticals Incorporated | $35.29 | 2024 | Iovera |
| Janssen Scientific Affairs, LLC | $27.15 | 2019 | |
| Pfizer INC. | $26.91 | 2023 | |
| Merck Sharp & Dohme LLC | $25.57 | 2025 | Keytruda, Keytruda Qlex |
| Astrazeneca Pharmaceuticals LP | $24.04 | 2021 | |
| Janssen Biotech, INC. | $22.80 | 2025 | Rybrevant |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.86 | 2024 | Verzenio, Jaypirca |
| Novocure INC. | $15.49 | 2021 | |
| Tactile Systems Technology INC | $14.08 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.